Results 271 to 280 of about 55,594 (335)

Famotidine-Induced Rash and Eosinophilia: A Case Report. [PDF]

Cureus
Junaid A, Graggaber J.
europepmc   +1 more source

Dapsone Hypersensitivity Syndrome in Leprosy. [PDF]

Am J Trop Med Hyg
Sagar HK.
europepmc   +1 more source

Levetiracetam-Aggravated Severe Treatment-Resistant Acne. [PDF]

Indian Dermatol Online J
Kothari R, Manoj R, Singh S, Gupta A.
europepmc   +1 more source

Pityriasis rosea-like drug eruption secondary to deucravacitinib

Nisal Punchihewa, Senhong Lee, Chin‐Guan Tan, Peter Foley   +3 more
openalex   +1 more source

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse events. [PDF]

Front Oncol
Nishizawa A, Itoh M, Inoue M, Makiguchi M, Koga F.   +4 more
europepmc   +1 more source

A Case of Drug-Induced Hypersensitivity Syndrome Caused by Apalutamide. [PDF]

IJU Case Rep
Tanaka Y, Fujimura Y, Morishita K, Kashiwagi Y, Katsuno S, Nagai T.   +5 more
europepmc   +1 more source

Toxic Epidermal Necrolysis Induced by First-Line Helicobacter pylori Eradication Therapy: A Case Report. [PDF]

Korean J Helicobacter Up Gastrointest Res
Chae YW, Seo SI, Shin WG.
europepmc   +1 more source

Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo. [PDF]

JAAD Case Rep
Concannon HR, Ku RG, Brazel M, Selim MA, Fresco A.   +4 more
europepmc   +1 more source

Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum reactions to immune checkpoint inhibitor therapy and safety of rechallenge: A retrospective review. [PDF]

JAAD Case Rep
Mattson G, Gutierrez R, Haemel A, Shinkai K, Arakaki R, Fox L, Dobry A.   +6 more
europepmc   +1 more source